Calithera Biosciences Depreciation & Amortization 2011-2026 | CALA

Annual Depreciation & Amortization Calithera Biosciences

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
300 K	400 K	500 K	505 K	365 K	297 K	404 K	361 K	281 K	269 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
505 K	269 K	368 K

Quarterly Depreciation & Amortization Calithera Biosciences

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	190 K	128 K	64 K	-	215 K	146 K	73 K	-	282 K	196 K	105 K	-	366 K	250 K	125 K	-	375 K	248 K	124 K	-	254 K	164 K	80 K	-	222 K	152 K	85 K	-	320 K	228 K	109 K	-	257 K	155 K	73 K	-	210 K	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
375 K	64 K	186 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Heron Therapeutics HRTX	2.31 M	$ 0.8	2.7 %	$ 133 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 19.23	-1.38 %	$ 899 M	USA
Altimmune ALT	112 K	$ 3.44	2.99 %	$ 303 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.63	0.77 %	$ 16.5 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Incyte Corporation INCY	93.3 M	$ 90.45	-0.36 %	$ 17.7 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Inovio Pharmaceuticals INO	2.62 M	$ 1.61	1.9 %	$ 35.7 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	311 K	$ 12.84	0.78 %	$ 774 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
KalVista Pharmaceuticals KALV	941 K	$ 16.6	-2.35 %	$ 824 M	Britain
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Karyopharm Therapeutics KPTI	340 K	$ 6.66	-12.71 %	$ 812 K	USA
Keros Therapeutics KROS	1.51 M	$ 11.24	2.55 %	$ 418 M	USA
Clovis Oncology CLVS	8.5 M	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Longeveron LGVN	800 K	$ 0.95	-2.71 %	$ 16.7 B	USA
Denali Therapeutics DNLI	7.8 M	$ 21.09	4.56 %	$ 3.47 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	1.4 M	$ 4.42	4.25 %	$ 734 M	Canada
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA